7.75
5.26%
-0.43
Handel nachbörslich:
7.75
Pharming Group N V Adr Aktie (PHAR) Neueste Nachrichten
Pharming Group to participate in November investor conference - GlobeNewswire Inc.
Oppenheimer cuts Pharming Group stock target, Outperform on Q3 results - Investing.com India
Earnings call: Pharming Group NV reports growth amid CEO transition - Investing.com
Earnings call: Pharming Group NV sees robust growth in Q3, CEO to step down - Investing.com
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last? - Yahoo Finance
Earnings call: Pharming Group reports robust growth and pipeline expansion - Investing.com India
Pharming Group stock hits 52-week low at $6.9 amid challenges - Investing.com
Shoals Technologies, Affirm Holdings, Apple And Other Big Stocks Moving Higher On Tuesday By Benzinga - Investing.com UK
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ... - Investing.com UK
J.M. Smucker Posts Upbeat Earnings, Joins Toro Company, United Natural Foods, Semtech And Other Big Stocks ... - Investing.com UK
Bath & Body Works, Designer Brands And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionBa - Benzinga
Bath & Body Works, Designer Brands And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session By Benzinga - Investing.com UK
Magenta (MGTA) Down on Pipeline Update for Leukemia Drug - Yahoo Canada Shine On
Earnings call: Pharming Group reports strong Q1 growth, eyes global expansion By Investing.com - Investing.com UK
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains? - Yahoo Finance
Landsbankinn hf.: Results of the 2024 AGM of Landsbankinn | GlobeNewswire by notified - NTB Kommunikasjon
Heineken® Celebrates Historic Irish Pubs With Virtual Museums Launch | GlobeNewswire by notified - NTB Kommunikasjon
PHAR Stock Quote Price and Forecast - CNN
PHARMING GROUP NV Trade Ideas — TRADEGATE:PHGN — TradingView - TradingView
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up - Nasdaq
How Investors Can Grab Better Returns for Retail and Wholesale Using the Zacks ESP Screener - Zacks Investment Research
Wolters Kluwer to Acquire eOriginal | GlobeNewswire by notified - NTB Kommunikasjon
PHARM Stock Price and Chart — EURONEXT:PHARM - TradingView
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):